What is STOMP?
The primary aim of the STOMP project is to improve the health and quality of life of people with a learning disability, autism or both by reducing the inappropriate use of psychotropic drugs as a "chemical restraint" to control challenging behaviour, where other more appropriate treatment options may be considered.
"Public Health England have estimated that on an average day in England, between 30,000 and 35,000 adults with a learning disability, autism or both are taking a prescribed antipsychotic, an antidepressant or both without appropriate clinical indications (psychosis or affective/anxiety disorder). A substantial proportion of people with a learning disability, autism or both who are prescribed psychotropic drugs for behavioural purposes can safely have their drugs reduced or withdrawn" (NHSE, 2016, p.3).
The Trust has signed up to the STOMP Pledge (see below) and is active in implementing plans to meet the highlighted goals of STOMP. As this work develops we will add further updates and links through these pages.